163 related articles for article (PubMed ID: 24367525)
1. Angiopoietins modulate endothelial adaptation, glomerular and podocyte hypertrophy after uninephrectomy.
Chiang WC; Lai CF; Su CT; Peng WH; Wu CF; Chang FC; Chen YT; Lin SL; Chen YM; Wu KD; Lu KS; Tsai TJ
PLoS One; 2013; 8(12):e82592. PubMed ID: 24367525
[TBL] [Abstract][Full Text] [Related]
2. A potential pathological role of angiopoietins expression in glomeruli during progressive glomerulisclerosis related to podocyte injury.
Lu Y; Deng A; Yang X; Liu J; Zhu Z
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(3):294-7. PubMed ID: 16961273
[TBL] [Abstract][Full Text] [Related]
3. Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor.
Satchell SC; Harper SJ; Tooke JE; Kerjaschki D; Saleem MA; Mathieson PW
J Am Soc Nephrol; 2002 Feb; 13(2):544-550. PubMed ID: 11805186
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated gene transfer of TGF-β1 to the renal glomeruli leads to proteinuria.
Ghayur A; Liu L; Kolb M; Chawla A; Lambe S; Kapoor A; Margetts PJ
Am J Pathol; 2012 Mar; 180(3):940-951. PubMed ID: 22203053
[TBL] [Abstract][Full Text] [Related]
5. Stereological and immunogold studies on TIE1 and TIE2 localization in glomeruli indicate angiopoietin signaling in podocytes.
Logothetidou A; De Spiegelaere W; Van den Broeck W; Vandecasteele T; Couck L; Simoens P; Cornillie P
Micron; 2017 Jun; 97():6-10. PubMed ID: 28288344
[TBL] [Abstract][Full Text] [Related]
6. Reduced Krüppel-Like Factor 2 Aggravates Glomerular Endothelial Cell Injury and Kidney Disease in Mice with Unilateral Nephrectomy.
Zhong F; Mallipattu SK; Estrada C; Menon M; Salem F; Jain MK; Chen H; Wang Y; Lee K; He JC
Am J Pathol; 2016 Aug; 186(8):2021-2031. PubMed ID: 27317905
[TBL] [Abstract][Full Text] [Related]
7. Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction.
Wiggins JE; Goyal M; Sanden SK; Wharram BL; Shedden KA; Misek DE; Kuick RD; Wiggins RC
J Am Soc Nephrol; 2005 Oct; 16(10):2953-66. PubMed ID: 16120818
[TBL] [Abstract][Full Text] [Related]
8. Angiopoietin 1 and 2 gene and protein expression is differentially regulated in acute anti-Thy1.1 glomerulonephritis.
Câmpean V; Karpe B; Haas C; Atalla A; Peters H; Rupprecht H; Liebner S; Acker T; Plate K; Amann K
Am J Physiol Renal Physiol; 2008 May; 294(5):F1174-84. PubMed ID: 18272601
[TBL] [Abstract][Full Text] [Related]
9. Angiopoietins and diabetic nephropathy.
Gnudi L
Diabetologia; 2016 Aug; 59(8):1616-20. PubMed ID: 27207083
[TBL] [Abstract][Full Text] [Related]
10. Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease.
Dessapt-Baradez C; Woolf AS; White KE; Pan J; Huang JL; Hayward AA; Price KL; Kolatsi-Joannou M; Locatelli M; Diennet M; Webster Z; Smillie SJ; Nair V; Kretzler M; Cohen CD; Long DA; Gnudi L
J Am Soc Nephrol; 2014 Jan; 25(1):33-42. PubMed ID: 24009238
[TBL] [Abstract][Full Text] [Related]
11. Fn14 in podocytes and proteinuric kidney disease.
Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
[TBL] [Abstract][Full Text] [Related]
12. Laminin-1 reexpression in Alport mouse glomerular basement membranes.
Abrahamson DR; Prettyman AC; Robert B; St John PL
Kidney Int; 2003 Mar; 63(3):826-34. PubMed ID: 12631063
[TBL] [Abstract][Full Text] [Related]
13. Angiopoietin-like protein 3 regulates the motility and permeability of podocytes by altering nephrin expression in vitro.
Gao X; Xu H; Liu H; Rao J; Li Y; Zha X
Biochem Biophys Res Commun; 2010 Aug; 399(1):31-6. PubMed ID: 20633534
[TBL] [Abstract][Full Text] [Related]
14. Angiopoietin-Like-4, a Potential Target of Tacrolimus, Predicts Earlier Podocyte Injury in Minimal Change Disease.
Li JS; Chen X; Peng L; Wei SY; Zhao SL; Diao TT; He YX; Liu F; Wei QJ; Zhang QF; Li B
PLoS One; 2015; 10(9):e0137049. PubMed ID: 26352670
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of the angiopoietins during porcine metanephric kidney development.
De Spiegelaere W; Cornillie P; Simoens P; Van den Broeck W
Acta Histochem; 2011 Sep; 113(5):585-90. PubMed ID: 20598355
[TBL] [Abstract][Full Text] [Related]
16. OPN deficiency results in severe glomerulosclerosis in uninephrectomized mice.
Schordan S; Grisk O; Schordan E; Miehe B; Rumpel E; Endlich K; Giebel J; Endlich N
Am J Physiol Renal Physiol; 2013 Jun; 304(12):F1458-70. PubMed ID: 23552865
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin correlates with glomerular capillary loss in anti-glomerular basement membrane glomerulonephritis.
Yuan HT; Tipping PG; Li XZ; Long DA; Woolf AS
Kidney Int; 2002 Jun; 61(6):2078-89. PubMed ID: 12028448
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of podocyte-secreted angiopoietin-like-4 in diabetic nephropathy.
Ma J; Chen X; Li JS; Peng L; Wei SY; Zhao SL; Li T; Zhu D; He YX; Wei QJ; Li B
Endocrine; 2015 Jun; 49(2):373-84. PubMed ID: 25424436
[TBL] [Abstract][Full Text] [Related]
19. VEGF and angiopoietins in diabetic glomerulopathy: how far for a new treatment?
Dei Cas A; Gnudi L
Metabolism; 2012 Dec; 61(12):1666-73. PubMed ID: 22554833
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietins: microvascular modulators with potential roles in glomerular pathophysiology.
Satchell SC; Mathieson PW
J Nephrol; 2003; 16(2):168-78. PubMed ID: 12768063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
